BiotechTube
Home/Candel Therapeutics/Jason Amello
JA

Jason Amello

Chief Financial Officer

Candel Therapeutics

Roles

Chief Financial OfficeratCandel Therapeutics
Chief Financial Officer and TreasureratTScan Therapeutics

Therapeutic Areas

Oncology

Candel Therapeutics Pipeline

DrugIndicationPhase
CAN-2409Non-Small Cell Lung Cancer (NSCLC)Phase 3
CAN-3110Recurrent High-Grade GliomaPhase 1

Leadership Team at Candel Therapeutics

PP
Paul Peter Tak
President and Chief Executive Officer
FG
Francesco G. Marincola
Chief Scientific Officer
GT
Gary Temple
Chief Development Officer
RM
Ronald Martell
Chairman of the Board
View full Candel Therapeutics profile